The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Inactivation of HAUSP in vivo modulates p53 function.
Open accessAbstract
Hausp is a deubiquitinase that has been shown to regulate the p53-Mdm2 pathway. Cotransfection of p53 and Hausp stabilizes p53 through the removal of ubiquitin moieties from polyubiquitinated p53. Interestingly, knockout or RNA interference-mediated knockdown of Hausp in human cells also resulted in the stabilization of p53 due to the destabilization of Mdm2, suggesting a dynamic role of Hausp in p53 activation. To understand the physiological functions of Hausp, we generated hausp knockout mice. Hausp knockout mice die during early embryonic development between embryonic days E6.5 and E7.5. The hausp knockout embryos showed p53 activation, but no apparent increase in apoptosis. Embryonic lethality was caused by a dramatic reduction in proliferation and termination in development, in part due to p53 activation and/or abrogation of p53-independent functions. Although deletion of p53 did not completely rescue the embryonic lethality of the hausp knockout, embryonic development was extended in both hausp and p53 double knockout embryos. These data show that Hausp has a critical role in regulating the p53-Mdm2 pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“USP7 is an essential enzyme; its homozygous knockout in mice results is early embryonic lethality (Kon et al., 2010)”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Kon et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,523
Ubiquitin: structures, functions, mechanisms
Pickart, C. M., & Eddins, M. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.019 · Cited by 1,491
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“However, combining a p53-null background with the mdm2 knockout rescues this phenotype, suggesting that Mdm2 is a major negative regulator of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 1×
“However, combining a p53-null background with the mdm2 knockout rescues this phenotype, suggesting that Mdm2 is a major negative regulator of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,048
Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 731
Cited by
Sorted by citations
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Self-citationChauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589
p53 post-translational modification: deregulated in tumorigenesis
Dai, C., & Gu, W. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 547
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V., Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2011) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 463
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 468
Deubiquitylases From Genes to Organism
Clague, M. J., Barsukov, I., Coulson, J. M., Liu, H., Rigden, D. J., & Urbé, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00002.2013 · Cited by 439
p53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Wang, L., Wu, C., Rajasekaran, N., & Shin, Y. K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495956 · Cited by 360
USP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya, L., Di Lello, P., Rougé, L., Pastor, R., Clark, K. R., Drummond, J., Kleinheinz, T., Lin, E., Upton, J.-P., Prakash, S., et al. (2017) · Nature · doi:10.1038/nature24006 · Cited by 333
Faesen, A. C., Dirac, A. M. G., Shanmugham, A., Ovaa, H., Anastassis Perrakis, A., & Sixma, T. K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.034 · Cited by 262
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
Zou, Q., Jin, J., Hu, H., Li, H. S., Romano, S., Xiao, Y., Nakaya, M., Zhou, X., Cheng, X., Yang, P., et al. (2014) · Nature Immunology · doi:10.1038/ni.2885 · Cited by 253
The Multifaceted Roles of USP7: New Therapeutic Opportunities
Nicholson, B., & Kumar, S. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9185-5 · Cited by 249
Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
Gavory, G., O'Dowd, C. R., Helm, M. D., Flasz, J., Arkoudis, E., Dossang, A., Hughes, C., Cassidy, E., McClelland, K., Odrzywol, E., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2528 · Cited by 224
Hao, Y.-H., Fountain, M. D., Fon Tacer, K., Xia, F., Bi, W., Kang, S.-H. L., Patel, A., Rosenfeld, J. A., Le Caignec, C., Isidor, B., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.033 · Cited by 206
HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
Tavana, O., Li, D., Dai, C., López, G., Banerjee, D., Kon, N., Chen, C., Califano, A., Yamashiro, D. J., Sun, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4180 · Cited by 202
USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan, Y.-H., Cheng, J., Vasudevan, S. A., Dou, J., Zhang, H., Patel, R. H., Ma, I. T., Rojas, Y., Zhao, Y., Yu, Y., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.400 · Cited by 199
Felle, M., Joppien, S., Németh, A., Diermeier, S. D., Thalhammer, V., Dobner, T., Kremmer, E., Kappler, R., & Längst, G. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr528 · Cited by 208
Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7.
Lamberto, I., Liu, X., Seo, H.-S., Schauer, N. J., Iacob, R. E., Hu, W., Das, D., Mikhailova, T., Weisberg, E. L., Engen, J. R., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.003 · Cited by 192
USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
Palazón‐Riquelme, P., Worboys, J. D., Green, J., Valera, A., Martín‐Sánchez, F., Pellegrini, C., Brough, D., & López‐Castejón, G. (2018) · EMBO Reports · doi:10.15252/embr.201744766 · Cited by 194
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186
Self-citationUSP7: Structure, substrate specificity, and inhibition
Pozhidaeva, A., & Bezsonova, I. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.02.005 · Cited by 178
“USP7 knockout was shown to be lethal in mice (8,9).”
BackgroundThe role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168
Limiting the power of p53 through the ubiquitin proteasome pathwayPreprint
Pant, V., & Lozano, G. (2014) · Genes & Development · doi:10.1101/gad.247452.114 · Cited by 170
Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1
Qin, W., Leonhardt, H., & Spada, F. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22998 · Cited by 172
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.
Bhattacharya, S., Chakraborty, D., Basu, M., & Ghosh, M. K. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0012-y · Cited by 162
Chao, C. C. ‐. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.015 · Cited by 155
Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
Antao, A. M., Tyagi, A., Kim, K.-S., & Ramakrishna, S. (2020) · Cancers · doi:10.3390/cancers12061579 · Cited by 156
USP7 is a SUMO deubiquitinase essential for DNA replication.
Lecona, E., Rodriguez-Acebes, S., Specks, J., Lopez-Contreras, A. J., Ruppen, I., Murga, M., Muñoz, J., Mendez, J., & Fernandez-Capetillo, O. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3185 · Cited by 148
Durcan, T. M., Kontogiannea, M., Thorarinsdottir, T., Fallon, L., Williams, A. J., Djarmati, A., Fantaneanu, T. A., Paulson, H. L., & Fon, E. A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq452 · Cited by 147
Deubiquitinases and the new therapeutic opportunities offered to cancer
Pfoh, R., Lacdao, I. K., & Saridakis, V. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0516 · Cited by 144
Wang, Z., Kang, W.-T., Li, O., Qi, F., Wang, J., You, Y., He, P., Suo, Z., Zheng, Y., & Liu, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.005 · Cited by 141
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
Reddy, B. A., van der Knaap, J. A., Bot, A. G. M., Mohd-Sarip, A., Dekkers, D. H. W., Timmermans, M. A. M., Martens, J. W. M., Demmers, J., & Verrijzer, C. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.017 · Cited by 133
Attenuating the p53 Pathway in Human Cancers: Many Means to the Same EndPreprint
Wasylishen, A. R., & Lozano, G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026211 · Cited by 131
Wu, H.-T., Kuo, Y.-C., Hung, J.-J., Huang, C.-H., Chen, W.-Y., Chou, T.-Y., Chen, Y., Chen, Y.-J., Chen, Y.-J., Cheng, W.-C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13644 · Cited by 129
Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade
Wang, Y., Jiang, Y., Ding, S., Li, J., Song, N., Ren, Y., Hong, D., Wu, C., Li, B., Wang, F., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0091-x · Cited by 128
USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin
Ji, L., Lu, B., Zamponi, R., Charlat, O., Aversa, R. J., Yang, Z., Sigoillot, F. D., Zhu, X., Hu, T., Reece-Hoyes, J. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12143-3 · Cited by 135
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114
“Telomeres are protein-nucleotide structures at the termini of each eukaryotic chromosome, which in humans contain 10 to 15 kb of a repeating hexanucleotide sequence (Kong et al., 2013).”
BackgroundTSPYL5 suppresses p53 levels and function by physical interaction with USP7.
Epping, M. T., Meijer, L. A. T., Krijgsman, O., Bos, J. L., Pandolfi, P. P., & Bernards, R. (2011) · Nature Cell Biology · doi:10.1038/ncb2142 · Cited by 117
Role of the nucleus in apoptosis: signaling and execution
Prokhorova, E. A., Zamaraev, A. V., Kopeina, G. S., Zhivotovsky, B., & Lavrik, I. N. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2031-y · Cited by 116
DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization
Papp, S. J., Huber, A., Jordan, S. D., Kriebs, A., Nguyen, M., Moresco, J. J., Yates, J. R., & Lamia, K. A. (2015) · eLife · doi:10.7554/elife.04883 · Cited by 117
Mdm2 and MdmX partner to regulate p53
Wang, X., & Jiang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.049 · Cited by 117
Modulation of the p53/MDM2 interplay by HAUSP inhibitors
Tavana, O., & Gu, W. J. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw049 · Cited by 110
Yang, W.-L., Zhang, X., & Lin, H.-K. (2010) · Oncogene · doi:10.1038/onc.2010.190 · Cited by 103
Regulation of USP7: A High Incidence of E3 Complexes
Kim, R. Q., & Sixma, T. K. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.028 · Cited by 97
Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
Sun, X., Ding, Y., Zhan, M., Li, Y., Gao, D., Wang, G., Gao, Y., Li, Y., Wu, S., Lu, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08334-7 · Cited by 94
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
Jin, Q., Martinez, C. A., Arcipowski, K. M., Zhu, Y., Gutierrez-Diaz, B. T., Wang, K. K., Johnson, M. R., Volk, A. G., Wang, F., Wu, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1740 · Cited by 98
Ma, P., Yang, X., Kong, Q., Li, C., Yang, S., Li, Y., & Mao, B. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00731-14 · Cited by 95
Deubiquitination of Ci/Gli by Usp7/HAUSP Regulates Hedgehog Signaling
Zhou, Z., Yao, X., Li, S., Xiong, Y., Dong, X., Zhao, Y., Jiang, J., & Zhang, Q. H. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.05.016 · Cited by 90
Roles of HAUSP-mediated p53 regulation in central nervous system development
Kon, N., Zhong, J., Kobayashi, Y., Li, M., Szabolcs, M., Ludwig, T., Canoll, P. D., & Gu, W. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.12 · Cited by 79
WDR20 Regulates Activity of the USP12·UAF1 Deubiquitinating Enzyme Complex
Kee, Y., Yang, K., Cohn, M. A., Haas, W., Gygi, S. P., & D’Andrea, A. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095141 · Cited by 85
Zhao, G., Lin, Z., Lu, C., Gu, J., Yuan, Y., Xu, F., Liu, R., Ge, D., & Ding, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2773-4 · Cited by 86
Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar, A., Shibata, E., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-13 · Cited by 83
Cellular and disease functions of the Prader–Willi Syndrome gene MAGEL2
Tacer, K. F., & Potts, P. R. (2017) · Biochemical Journal · doi:10.1042/bcj20160616 · Cited by 81
Reiner, T., Parrondo, R. D., Pozas, A. D. L., Palenzuela, D. L., & Perez‐Stable, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056234 · Cited by 77
Morra, F., Merolla, F., Napolitano, V., Ilardi, G., Miro, C., Paladino, S., Staibano, S., Cerrato, A., & Celetti, A. (2017) · Oncotarget · doi:10.18632/oncotarget.16463 · Cited by 74
Functional analysis of deubiquitylating enzymes in tumorigenesis and development
Cheng, J., Guo, J., North, B. J., Wang, B., Cui, C., Li, H., Tao, K., Zhang, L., & Wei, W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188312 · Cited by 75
Lv, L., Xiao, X., Gu, Z., Zeng, F., Huang, L., & Jiang, G. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0585-4 · Cited by 72
Chen, S.-T., Okada, M., Nakato, R., Izumi, K., Bando, M., & Shirahige, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628255 · Cited by 69
Regulation of the p53 pathway by ubiquitin and related proteins
Hock, A., & Vousden, K. H. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.011 · Cited by 70
Yi, J., Li, H., Chu, B., Kon, N., Hu, X., Hu, J., Xiong, Y., Kanıskan, H. Ü., Jin, J. J., & Gu, W. J. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01180-7 · Cited by 70
Wei, R., Liu, X., Yu, W., Yang, T., Cai, W., Liu, J., Huang, X. S., Xu, G., Zhao, S., Yang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3671 · Cited by 72
Jiang, L., Xiong, J., Zhan, J., Yuan, F., Tang, M., Zhang, C., Cao, Z., Chen, Y., Lu, X., Li, Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780130 · Cited by 71
The role of UBL domains in ubiquitin-specific proteases
Faesen, A. C., Luna‐Vargas, M. P. A., & Sixma, T. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120004 · Cited by 66
Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells
Wei, X., Guo, J., Li, Q., Jia, Q., Jing, Q., Li, Y., Zhou, B., Chen, J., Gao, S., Zhang, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau7887 · Cited by 66
Giovinazzi, S., Morozov, V. M., Summers, M. K., Reinhold, W. C., & Ishov, A. M. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.169 · Cited by 65
Gao, Y., Koppen, A., Rakhshandehroo, M., Taşdelen, I., van de Graaf, S. F. J., van Loosdregt, J., van Beekum, O., Hamers, N., van Leenen, D., Berkers, C. R., et al. (2013) · Nature Communications · doi:10.1038/ncomms3656 · Cited by 65
USP7 Cooperates with SCML2 To Regulate the Activity of PRC1
Lecona, E., Narendra, V. K., & Reinberg, D. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01197-14 · Cited by 60
Ni, W., Lin, S., Bian, S., Zheng, W., Qu, L., Fan, Y., Lu, C., Xiao, M., & Zhou, P. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03075-8 · Cited by 59
Dual-utility NLS drives RNF169-dependent DNA damage responses
An, L., Jiang, Y., Ng, H. H. W., Man, E. P. S., Chen, J., Khoo, U., Gong, Q., & Huen, M. S. Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616602114 · Cited by 61
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
He, Y., Wang, S., Tong, J., Jiang, S., Yang, Y., Zhang, Z., Xu, Y., Zeng, Y., Cao, B., Moran, M. F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010724 · Cited by 55
The USP7 protein interaction network and its roles in tumorigenesis
Al-Eidan, A., Wang, Y., Skipp, P., & Ewing, R. M. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2020.10.004 · Cited by 57
Peng, Y., Liu, Y., Gao, Y., Yuan, B., Qi, X., Fu, Y., Zhu, Q., Cao, T., Zhang, S., Yin, L., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1457-8 · Cited by 54
Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease
Rawat, R., Starczynowski, D. T., & Ntziachristos, P. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.02.008 · Cited by 54
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Harakandi, C., Nininahazwe, L., Xu, H., Liu, B., He, C., Zheng, Y., & Zhang, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105273 · Cited by 53
The role of deubiquitinating enzymes in cancer drug resistance
Tanguturi, P., Kim, K.-S., & Ramakrishna, S. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04046-8 · Cited by 49
Wertz, I. E., & Murray, J. M. (2019) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2019.02.003 · Cited by 48
Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?
López‐Castejón, G., & Edelmann, M. J. (2016) · Mediators of Inflammation · doi:10.1155/2016/3481371 · Cited by 49
Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors
Li, P., & Liu, H.-M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112107 · Cited by 50
Deubiquitylases in developmental ubiquitin signaling and congenital diseases
Basar, M. A., Beck, D. B., & Werner, A. A. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00697-5 · Cited by 48
Wu, J., Kumar, S., Wang, F., Wang, H., Chen, L., Arsenault, P., Mattern, M. R., & Weinstock, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00498 · Cited by 47
Li, J., Wang, R., Jin, J.-Y., Han, M., Chen, Z., Gao, Y., Hu, X., Zhu, H., Gao, H., Lu, K., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00188-4 · Cited by 45
HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response
Lim, K., Park, J.-J., Gu, B., Kim, J.-O., Park, S. G., & Baek, K. (2015) · Scientific Reports · doi:10.1038/srep12793 · Cited by 43
Fraile, J. M., Campos-Iglesias, D., Rodríguez, F. J., Español, Y., & Freije, J. M. P. (2016) · Oncotarget · doi:10.18632/oncotarget.12769 · Cited by 41
Ohol, Y. M., Sun, M. T., Cutler, G., Leger, P. R., Hu, D. X., Biannic, B., Rana, P., Cho, C., Jacobson, S., Wong, S., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0184 · Cited by 41
USP7 limits CDK1 activity throughout the cell cycle
Galarreta, A., Valledor, P., Ubieto‐Capella, P., Lafarga, V., Zarzuela, E., Muñoz, J., Malumbres, M., Lecona, E., & Fernández-Capetillo, Ó. (2021) · The EMBO Journal · doi:10.15252/embj.201899692 · Cited by 39
The toxic effect of aflatoxin B1 on early porcine embryonic development
Shin, K., Guo, J., Niu, Y., & Cui, X. (2018) · Theriogenology · doi:10.1016/j.theriogenology.2018.06.002 · Cited by 39
Targeting PTEN Regulation by Post Translational Modifications
González-García, A., Garrido, A., & Carrera, A. C. (2022) · Cancers · doi:10.3390/cancers14225613 · Cited by 41
The equilibrium of tumor suppression: DUBs as active regulators of PTEN
Christine, A., Park, M. K., Song, S. J., & Song, M. S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00887-w · Cited by 41
Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1
Liang, L., Peng, Y., Zhang, J., Zhang, Y., Roy, M., Han, X., Xiao, X., Sun, S., Liu, H., Nie, L., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.206227 · Cited by 37
Dying to Survive—The p53 Paradox
Lees, A., Sessler, T., & McDade, S. S. (2021) · Cancers · doi:10.3390/cancers13133257 · Cited by 38
Deubiquitinases and cancer: A snapshot
Singh, N., & Singh, A. B. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.04.018 · Cited by 38
Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects
Khusbu, F. Y., Chen, F., & Chen, H. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3336 · Cited by 36
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia
Maat, H., Atsma, T. J., Hogeling, S. M., López, A. R., Jaques, J., Olthuis, M., de Vries, M. P., Gravesteijn, C., Brouwers-Vos, A. Z., van der Meer, N. K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102435 · Cited by 39
Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma
Yu, Z., Wei, X., Liu, L., Sun, H., Fang, T., Wang, L., Li, Y., Sui, W., Wang, K., He, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103950 · Cited by 36
USP7 manipulation by viral proteins
Bojagora, A., & Saridakis, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198076 · Cited by 37
Molecular mechanisms and functions of cytokine-inducible deubiquitinating enzymes
Lim, K., Ramakrishna, S., & Baek, K. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.007 · Cited by 30
Sun, Y., Cao, L., Sheng, X., Chen, J., Zhou, Y., Yang, C., Deng, T., Ma, H., Feng, P., Liu, J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.162 · Cited by 31
Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy
Pluciennik, A., Liu, Y., Molotsky, E., Marsh, G. B., Ranxhi, B., Arnold, F. J., St.-Cyr, S., Davidson, B. L., Pourshafie, N., Lieberman, A. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134565 · Cited by 30
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
Shin, S., Kim, C.-H., Jang, H.-R., & Yim, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228629 · Cited by 28
Zhu, S., Gu, H., Peng, C. Y., Xia, F., Cao, H., & Cui, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.849625 · Cited by 30
Metadata
- Authors
- Kon, N., Kobayashi, Y., Li, M., Brooks, C. L., Ludwig, T., & Gu, W.
- Affiliations
- Columbia University (US)
- Venue
- Oncogene
- Published
- 2009-11-30
- Volume
- 29
- Issue
- 9
- Pages
- 1270-1279
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC2857765
- OpenAlex
- W2037667982
- Cited by
- 176
- References
- 31
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 28 · 2019: 14 · 2018: 15 · 2017: 15 · 2016: 10 · 2015: 10 · 2014: 8 · 2013: 10 · 2012: 8
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (P01CA097403, R01CA129627)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- USP7, p53, MDM2, deubiquitinase, p53 stabilization, MDM2-p53 pathway, embryonic lethality, cell proliferation, knockout mice, p53-independent function, apoptosis
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Animals, Female, HeLa Cells, Humans, Substrate Specificity, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Mice, Knockout, Tumor Suppressor Proteins, Ubiquitin, RNA Interference, RNA, Small Interfering, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
